A transgenic rabbit model for human hypertrophic cardiomyopathy

Journal of Clinical Investigation

Volumn 104, Issue 12, 1999, Pages 1683-1692

  Marian, Ali J ^a,b   Wu, Yun ^a   Lim, Do Sun ^a   McCluggage, Meghan ^a   Youker, Keith ^a   Yu, Qun Tao ^a   Brugada, Ramon ^a   DeMayo, Francesco ^a   Quinones, Miguel ^a   Roberts, Robert ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Section of Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HYPERTROPHIC CARDIOMYOPATHY; MALE; MOLECULAR CLONING; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RABBIT; TRANSGENIC ANIMAL;

EID: 0033386313     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7956     Document Type: Article

References (60)

1. Maron, B.J., et al. 1995. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 92:785-789.
2. Wigle, E.D., Rakowski, H., Kimball, B.P., and Williams, W.G. 1995. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 92:1680-1692.
3. Ferrans, V.J., and Rodriguez, E.R. 1983. Specificity of light and electron microscopic features of hypertrophic obstructive and nonobstructive cardiomyopathy. Qualitative, quantitative and etiologic aspects. Eur. Heart J. 4(Suppl. F):9-22.
4. Maron, B.J., et al. 1996. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 276:199-204.
5. Marian, A.J., and Roberts, R. 1998. Molecular generic basis of hypertrophic cardiomyopathy: generic markers for sudden cardiac death. J. Cardiovasc. Electrophysiol. 9:88-99.
6. Watkins, H., et al. 1995. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332:1058-1064.
7. Marian, A.J., and Roberts, R. 1995. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation. 91:1336-1347.
8. Marian, A.J., and Roberts, R. 2000. Molecular pathogenesis of cardiomyopathies. In Cardiovascular pathology and physiology. 4th ed. N. Sperelakis, editor. Academic Press, San Diego, CA. In press.
9. Marian, A.J., Zhao, G., Seta, Y., Roberts, R., and Yu, Q.T. 1997. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ. Res. 81:76-85.
10. Rust, E.M., Albayya, F.P., and Metzger, J.M. 1999. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J Clin. Invest. 103:1459-1467.
11. Kim, S.J., et al. 1999. An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am. J. Physiol 276:H1780-H1787.
12. Oberst, L., et al. 1998. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J. Clin. Invest. 102:1498-1505.
13. Muthuchamy, M., et al. 1999. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ. Res. 85:47-56.
14. Tardiff, J.C., et al. 1998. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J. Clin. Invest. 101:2800-2811.
15. Geisterfer-Lowrance, A.A.,et al. 1996. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:731-734.
16. Yang, Q., et al. 1998. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J. Clin. Invest. 102:1292-1300.
17. Vikstrom, K.L., Factor, S.M., and Leinwand, L.A. 1996. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol. Med. 2:556-567.
18. Vemuri, R., et al. 1999. The stretch-activation response may be critical to the proper functioning of the mammalian heart. Proc. Natl. Acad. Sci. USA. 96:1048-1053.
19. 92: altered function precedes structural abnormalities. J. Mol. Cell. Cardiol. In press.
20. Cohen, M.V., Cooperman, L.B., and Rosenblum, R. 1975. Regional myocardial function in idiopathic hypertrophic subaortic stenosis. An echocardiographic study. Circulation. 52:842-847.
21. Beyar, R. 1995. Hypertrophic cardiomyopathy: functional aspects by tagged magnetic resonance imaging. Adv. Exp. Med. Biol. 382:293-301.
22. Mishiro, Y., et al. 1999. Regional left ventricular myocardial contraction abnormalities and asynchrony in patients with hypertrophic cardiomyopathy evaluated by magnetic resonance spatial modulation of magnetization myocardial tagging.Jpn. Circ. J. 63:442-446.
23. Hirota, Y., et al. 1982. Hypertrophic nononbstructive cardiomyopathy: a precise assessment of hemodynamic characteristics and clinical implications. Am. J. Cardiol. 50:990-997.
24. Swynghedauw, B. 1986. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol. Rev. 66:710-771.
25. Sugiura, S., et al. 1998. Distinct kinetic properties of cardiac myosin isoforms revealed by in vitro studies. Adv. Exp. Med. Biol. 453:125-130
26. Sugiura, S., et al. 1998. Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ. Res. 82:1029-1034.
27. Pagani, E.D., Shemin, R., and Julian, F.J. 1986. Tension-pCa relations of saponin-skinned rabbit and human heart muscle. J. Mol. Cell Cardiol. 18:55-66
28. Pagani, E.D., and Julian, F.J. 1984. Rabbit papillary muscle myosin isozymes and the velocity of muscle shortening. Circ. Res. 54:586-594.
29. Schwartz, K., et al. 1981. Myosin isoenzymic distribution correlates with speed of myocardial contraction. J. Mol. Cell Cardiol. 13:1071-1075.
30. Kavinsky, C.J., et al. 1984. Analysis of cloned mRNA sequences encoding subfragment 2 and part of subfragment 1 of alpha- and beta-myosin heavy chains of rabbit heart. J. Biol. Chem. 259:2775-2781.
31. Jaenicke, T., et al. 1990. The complete sequence of the human betamyosin heavy chain gene and a comparative analysis of its product. Genomics. 8:194-206.
32. Watkins, H., et al. 1992. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 326:1108-1114.
33. Marian, A.J., Yu, Q.T., Mann, D.L., Graham, F.L., and Roberts, R. 1995. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ. Res. 77:98-106.
34. Knight, K.L., Spicker-Polet, H., Kazdin, D.S., and Oi, V.T. 1988. Transgenic rabbits with lymphocytic leukemia induced by the c-myc oncogene fused with the immunoglobulin heavy chain enhancer. Proc. Natl. Acad. Sci. USA. 85:3130-3134.
35. Marian, A.J., et al. 1992. Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J. Clin. Invest. 90:2156-2165.
36. Yu, Q., Zhao, G., and Marian, A.J. 1999. In vivo short-term expression of a hypertrophic cardiomyopathy mutation in adult rabbit myocardium: myofibrillar incorporation without early disarray. Proc. Assoc. Am. Physicians. 45-56.
37. Chomczynski, P., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
38. Perryman, M.B., et al. 1992. Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. J. Clin. Invest. 90:271-277.
39. Yu, Q.T., et al. 1993. Hypertrophic cardiomyopathy mutarion is expressed in messenger RNA of skeletal as well as cardiac muscle. Circulation. 87:406-412.
40. Devereux, R.B., and Reichek, N. 1977. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 55:613-618.
41. Maron, B.J., Anan, T.J., and Roberts, W.C. 1981. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation. 63:882-894.
42. Maron, B.J., Sato, N., Roberts, W.C., Edwards, J.E., and Chandra, R.S. 1979. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation. 60:685-696.
43. Maron, B.J., and Roberts, W.C. 1979. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation. 59:689-706.
44. Lopez-De Leon, A., and Rojkind, M. 1985. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J. Histochem. Cytochem. 33:737-743.
45. Knotts, S., Sanchez, A., Rindt, H., and Robbins, J. 1996. Developmental Modulation of a beta myosin heavy chain promoter-driven transgene. Dev. Dyn. 206:182-192.
46. Knotts, S., Rindt, H., and Robbins, J. 1995. Position independent expression and developmental regulation is directed by the beta myosin heavy chain gene's 5′ upstream region in transgenic mice. Nucleic Acids Res. 23:3301-3309.
47. Rindt, H., Gulick, J., Knotts, S., Neumann, J., and Robbins, J. 1993. In vivo analysis of the murine beta-myosin heavy chain gene promoter. J. Biol. Chem. 268:5332-5338.
48. Marian, A.J., et al. 1995. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations. Eur. Heart J. 16:368-376.
49. Epstein, N.D., Cohn, G.M., Cyran, F., and Fananapazir, L. 1992. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu - Val mutation and a 403Arg - Gln mutation. Circulation. 86:345-352.
50. Assayag, P., et al. 1997. Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis. Cardiovasc. Res. 34:439-444.
51. Wu, T.J., et al. 1998. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J. Am. Coll. Cardiol. 32:187-196.
52. La Vecchia, L., et al. 1998. Ventricular late potentials, interstitial fibrosis, and right ventricular function in patients with ventricular tachycardia and normal left ventricular function. Am. J. Cardiol. 81:790-792.
53. Frohlich, E.D. 1998. Left ventricular hypertrophy and sudden death. J. AM. Coll. Cardiol. 32:1460-1462.
54. Spinto, P., and Maron, B.J. 1990. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 15:1552-1526.
55. Abchee, A., and Marian, A.J. 1997. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. J. Invest. Med. 45:191-196.
56. Janse, M.J., Opthof, T., and Kleber, A.G. 1998. Animal models of cardiac arrhythmias. Cardiovasc. Res. 39:165-177.
57. VanBuren, P., Harris, D.E., Alpert, N.R., and Warshaw, D.M. 1995. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ. Res. 77:439-444.
58. Holubarsch, C., et al. 1985. The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hyporhyroid rat myocardium. Circ. Res. 56:78-86.
59. Nakao, K., Minobe, W., Roden, R., Bristow, M.R., and Leinwand, L.A. 1997. Myosin heavy chain gene expression in human heart failure J. Clin. Invest. 100:2362-2370.
60. Lowes, B.D., et al. 1997. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J. Clin. Invest. 100:2315-2324.